Exhibition
Sept. 16 - 19, 2026 | Las Vegas, Nevada
ASNC2026 Exhibition and Sponsored Events
Join us at ASNC2026 to engage with ASNC’s esteemed industry partners. Through expert insights and hands-on guidance, these opportunities will help you and your team harness the latest tools and technologies, keeping your lab at the forefront of clinical excellence.
Thursday, Sept. 17
7:00 AM – 8:15 AM
Breakfast Symposium Sponsored by Pfizer
Title: Shaping the ATTR-CM Journey: Imaging Insights and Management Strategies
Speaker: Brett W. Sperry, MD, FASNC
Description: This session highlights the pivotal role of nuclear cardiologists across the full ATTR-CM care continuum. Featuring expert perspectives and a patient case study, the program will cover identification and diagnosis of ATTR-CM through nuclear imaging, as well as management with an oral medication option. Key clinical data for this agent will be reviewed. The session will also summarize published consensus recommendations for monitoring disease progression in ATTR-CM.
11:00 AM – 11:45 AM
Exhibitor Presentation Sponsored by GE HealthCare
Title: Building Cardiac PET Programs: Bridging Clinical Value to Confident Adoption
Speaker: April Mann, MBA, CNMT, NCT, RT(N), MASNC
Description: Cardiac PET is gaining rapid momentum as a preferred modality for detecting coronary artery disease, yet many healthcare organizations still face challenges turning clinical interest into successful program adoption.
Join April Mann, MBA, CNMT, NCT, RT(N), MASNC as she dives into the benefits of cardiac PET and the real-world barriers to implementation from workflow to team alignment and shares practical strategies to overcome them. Discover how education, peer learning, and case-based insights can accelerate the path from interest to execution.
12:15 PM – 1:15 PM
Lunch and Learn Sponsored by Bracco Diagnostics
Title: A New Century for Cardiac PET: Blood Flow Quantification as a Roadmap to Treatment
Speakers: K. Lance Gould, MD, MASNC and Nils Johnson, MD, MS
Objectives:
1. Apply the results of the Century randomized trial to incorporate cardiac PET into clinical practice.
2. Utilize absolute blood flow quantification to personalize treatment of complex clinical cases.
3. Appreciate the tradeoffs between Rb-82 and F-18 regarding respiratory and cardiac motion.
Friday, Sept. 18
12:15 PM – 1:15 PM
Lunch and Learn Sponsored by GE HealthCare
Title: Cardiac PET Reimagined: Bridging Evidence, Guidelines, and Clinical Impact
Speaker: René Packard, MD, PhD
Description: This session reviews the SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for FlyrcadoTM (flurpiridaz F 18 injection) PET Myocardial Perfusion Imaging, highlighting the supporting evidence and key clinical recommendations.
Join us, as we translate guidance into real-world practice by discussing technical, workflow, and operational considerations for implementing and scaling a cardiac PET program to drive meaningful clinical impact.
1:30 PM – 2:15 PM
Exhibitor Presentation Sponsored by AstraZeneca
Title: Advancing the Understanding of Transthyretin Amyloidosis (ATTR)
Speaker: John Venditto, MD, MBA
Description: Join an AstraZeneca and Ionis Pharmaceuticals-led scientific session focused on transthyretin amyloidosis (ATTR).
2:45 PM – 3:45 PM
Cases Over Cocktails and Mocktails
Join Alnylam, CDL Nuclear Technologies, and Jubilant Radiopharma during the Friday afternoon break for a series of engaging case presentations, all while savoring signature cocktails and mocktails.
-
Alnylam - Booth #109
ATTR Cardiac Amyloidosis: A Diagnostic Journey Guided by Imaging
Enjoy the Silent Punch mocktail while following a real-world patient case that illustrates the diagnostic journey of ATTR cardiac amyloidosis, from clinical presentation and multimodality imaging to treatment with an ATTR silencer.
Speaker: Mark Zenker, MD
Signature Mocktail: "Silent Punch"
-
CDL Nuclear Technologies - Booth #209
From Vision to Reality: Launching a Cardiac PET Program at Your Healthcare Organization
Enjoy The 360 Signature cocktail while following a real-world patient case and gaining practical insights into launching and sustaining a successful cardiac PET program, from implementation strategies to the clinical value of absolute myocardial blood flow quantification.
Speaker: Rupa Sanghani, MD, FASNC
Signature Cocktail: "The 360 Signature"
-
Jubilant Radiopharma - Booth #409
The Value of Cardiac PET: Case PresentationsExploring the role of Rb-82 PET imaging in myocardial disease through interactive patient case discussions and comparing the clinical benefits of cardiac PET and SPECT.
Speaker: Richard Weinberg, MD, PhD, FASNC
Signature Cocktail: "RUBY Radiance"
Saturday, Sept. 19
7:00 AM – 8:15 AM
Breakfast Symposium Sponsored by Alnylam: Introduction to AMVUTTRA® (vutrisiran)
Join Alnylam as they review the clinical profile of AMVUTTRA for the treatment of the cardiomyopathy of transthyretin-mediated amyloidosis (ATTR-CM) in adults.
Speakers: Ahmed Abuzaid, MD, EMHL, FASNC, and Vasvi Singh, MD, FASNC
These sessions are not part of the official ASNC2026 Annual Scientific Session as planned by the Program Committee.
Thank You to Our ASNC2026 Sponsors
PLATINUM
GOLD
SILVER
BRONZE
Thank You to Our ASNC2026 Exhibitors
Alexion
Alnylam Pharmecuticals
AstraZeneca Ionis
Bayer
Best Medical International
Bracco Diagnostics
BridgeBio
Cardiac Imaging
Cardinal Health
Cardiovascular Imaging Technologies
Catalyst MedTech
CDL Nuclear Technologies
Cedars-Sinai Medical Center
Cyclomedica
GE Healthcare
Intersocietal Accreditation Commission
INVIA
Jubilant Radiopharma
MedTrace Pharma
MIE America
Modern Nuclear
Molecular Imaging Services
MXR Imaging
Pfizer
Positron Corporation
RLS Radiopharmacies
Shared Imaging
Shared Medical Services
SIEMENS
Spectrum Dynamics
Studycast by Core Sound Imaging
SynterMed
Ultromics
United Imaging
Upbeat Cardiology
ASNC2026 Expo Hall Floor Plan
